Eleven pioneering Nordic healthtech companies have been selected to bring their health innovations to the Yorkshire and Humber region as part of the Propel International Boot Camp, delivered by Health Innovation Yorkshire & Humber.
The programme supports international small and medium-sized enterprises (SMEs) to enter the UK healthcare market, helping them align with NHS priorities, improve patient outcomes, and accelerate adoption within the NHS.
The selected companies are introducing a wide range of digital health and medical technology solutions, including:
- A digital app supporting maternal mental health during pregnancy
- An interactive touchscreen tablet promoting healthy ageing and social inclusion
- Advanced wound care products designed to improve patient comfort and reduce skin complications.
These innovations address key challenges facing the NHS, including workforce pressures, preventative care, ageing populations, and patient experience.
The Propel International Boot Camp attracts some of the world’s most promising health innovation companies to the UK, positioning Yorkshire and Humber as the first region to explore real-world testing, adoption, and impact. The programme, funded by our international partners, supports SMEs to navigate the UK healthcare system and accelerate their route to market.
The following Nordic innovators were selected to take part in the programme (please click each tab below to read more):
YetiCare is a Finnish health-tech company offering a large-format, interactive touch-table (“Yetitablet”) and a dedicated software environment designed to support healthy ageing, inclusion and meaningful activity in care settings. The solution is built for accessibility: a simplified launcher/UI with large icons and optimised visual settings supports users with mobility or visual impairments, while a library of tailored apps supports cognitive stimulation, motor skills, sensory engagement, rehabilitation, learning and group/social activities. The platform is positioned as a non-medical digital assistive tool for carers and organisations, aiming to reduce isolation and enable engaging, structured activity in environments such as elderly care, complex-needs care homes and special schools; the PDF also notes existing UK deployment.
Read more here: https://yeticare.fi/
EchoVice is a Danish medtech company developing EchoM, a single-use stabilisation device for transoesophageal echocardiography (TEE/TOE) probes used during structural heart procedures. The device is designed to mechanically stabilise and secure the probe to improve imaging consistency and procedural precision, while allowing clinicians to adjust and rotate the probe when needed without disrupting workflow—supporting better ergonomics and reducing operator workload. The PDF describes EchoM as being developed with cardiologists and “CE-mark ready” under MDR as a Class I medical device, with the company exploring early UK entry to understand regulatory, procurement and adoption requirements in NHS cardiac services.
Read more here: https://www.echovice.dk/
Omaia is a Swedish femtech/health-tech company building an AI-enabled digital programme to support maternal mental health during pregnancy, focusing on reducing anxiety, stress and fear related to childbirth. The programme combines clinical expertise with AI to deliver personalised, always-available support, drawing on evidence-based psychological approaches (the PDF cites CBT and ACT with input from psychologists and midwives). Omaia positions the product as a health-tech programme (not a medical device), with the pregnant person as the user and healthcare systems/insurers/employers as the intended payers, and the UK described as a priority launch market aligned with prevention and women’s health priorities.
Read more here: https://www.omaia.ai/
Abomics is a Finnish precision-medicine company specialising in pharmacogenetics (PGx). Its core offering is a software-based PGx interpretation service that transforms genetic test results (from partner laboratories) into clear prescribing and dose recommendations to support safer, more effective medication decisions—particularly relevant where genetic variation affects response to antidepressants, pain medicines and cardiovascular treatments. Abomics also provides curated databases (including GeneRx) covering pharmacogenetic knowledge and related medication decision support content; the PDF highlights integration of international guidelines and ongoing progress toward IVDR certification, with the UK framed as a priority growth market aligned to NHS genomics and personalised care ambitions.
Read more here: https://abomicspgx.com/
Upptimely is a Scandinavian SaaS platform helping healthcare providers gain control over medical equipment operations, including device inventories, service contracts and supplier performance. The platform creates a single, web-based register of equipment across an organisation and supports more intelligent management by enabling visibility into equipment status and performance—aiming to reduce downtime, unnecessary service costs and underutilisation so more capacity can be directed to patient care. The PDF also describes monitoring of SLAs/uptime and workflow integration with suppliers (e.g., service tickets), supporting benchmarking and operational decision-making as Upptimely explores UK market entry.
Read more here: https://www.upptimely.com/
ExAC is a Norwegian company focused on improving outcomes from severe bleeding—particularly postpartum haemorrhage (PPH) and pelvic trauma—through external aortic compression (EAC). Its flagship product, the ExAC Trainer, is described as a high-fidelity manikin/simulator enabling clinicians to practise EAC (and associated techniques such as uterine massage) in realistic obstetric and trauma scenarios. ExAC pairs the simulator with structured training approaches (including “train-the-trainer” models, per the PDF) to support implementation into local protocols and safer adoption at scale, with activity across Nordic countries and exploration of wider NHS uptake.
Read more here: https://www.exac.no/
Crisis Linguistics (Somsagt AS) is a Norwegian health-communication company developing AI-based simulation training to improve the quality, safety and consistency of emergency call handling. The PDF describes an AI simulator that recreates high-intensity 999/111-style scenarios so call-takers can practise responding to distressed callers, managing escalation and making faster, safer decisions—supporting workforce resilience and performance. In addition, an external project listing describes “Rescuevoice Pro” as a simulator for emergency operators (with a defined R&D project and named contact), reinforcing the product’s positioning as structured training infrastructure for emergency communications.
Read more here: https://www.somsagt.no/
Nil Medical develops Vestpack, a wearable solution designed to help patients—especially children—move more freely while carrying essential therapy equipment. The website positions Vestpack as an ergonomic, discreet vest that protects fluids, pumps and tubing inside the garment to reduce the burden of traditional infusion stands and improve mobility and comfort. The PDF further frames Vestpack as a lightweight pouch system that keeps medical equipment secure and accessible during treatment or daily activities, supporting dignity, safety and more independent care in areas such as paediatrics, cancer care, palliative care, nutrition/hydration and long-term conditions.
Read more here: https://www.nilmedical.com/
Global Health Technology is a Norwegian medical-device company developing wound and ostomy care products under the Erland Care brand. The company’s portfolio includes the Erland Care Stoma Pad, described as an all-in-one product intended to support secure pouch/plate attachment and reduce leakage and associated peristomal skin complications, and Erland Care Protective Skin, a multifunctional silicone dressing designed to bind wound fluid away from skin and support healing across a range of wound types (including peristomal wounds, ulcers and post-op applications). The Nordic Bootcamp PDF positions the company around improving patient comfort, reducing skin complications, preventing leakage-related harm, and building evidence via UK clinician interest and NHS evaluations.
Read more here: https://www.globalhealthtechnology.no/
MoniDose is a Finnish health-technology company developing an AI-driven, IoT-enabled medication dispensing and management system for home care and elderly services. The website describes an automatic dosing/dispensing approach aimed at improving medication safety and reducing errors in nursing homes and home healthcare, while the PDF adds an ecosystem view: a roll-based dispenser plus a secure cloud platform and mobile tools used by nurses, caregivers and pharmacies. Across sources, the solution is positioned around real-time monitoring, alerts, auditability/oversight and analytics to support medicines optimisation, adherence and safer management of complex medication regimes in community and residential settings.
Read more here: https://monidose.fi/
Dossier is a cloud-based platform for clinical competency management, helping healthcare organisations manage, track and evidence competencies, training and compliance across large workforces. The website frames competency management as centralising validation of skills across roles, departments and locations to support safe patient care and regulatory readiness, providing leaders real-time visibility without manual tracking. The PDF adds scale and operational value: Dossier consolidates multiple learning/training systems into a single dashboard, enabling visibility of staff readiness, identification of gaps and support for patient safety, quality assurance and workforce efficiency – positioned as an alternative to fragmented or paper-based processes.
Read more here: https://dossier.com/
Neville Young, Director of Enterprise and Innovation at Health Innovation Yorkshire & Humber, said: “It’s fantastic to support global innovators as they enter the UK healthcare market. As part of our mission to drive economic growth and improve health and wellbeing across the region, the Propel Boot Camp attracts international businesses to the NHS – helping to secure investment and create jobs for the region.
“The programme gives innovators a clear route into the UK healthcare system, with the opportunity to establish a base in Yorkshire and the Humber.
“SMEs take part in a five-day intensive programme covering five key areas: the NHS, legal, finance and funding, networking, and growth and spread. Participants gain access to subject matter experts and work directly with local NHS stakeholders and the wider HealthTech ecosystem across the region.”
Emma Granlund, Interim CEO at YetiCare Oy, one of the Nordic Propel cohort, said: “For us, the bootcamp is about truly cracking the UK market – understanding how the NHS works in practice, navigating regulation and procurement, and building the right partnerships to scale. We want to leave with a clear roadmap, strong connections, and real momentum for our UK expansion.”
Through initiatives such as the Propel Boot Camps, Health Innovation Yorkshire & Humber continues to strengthen the region’s reputation as a gateway for international health innovation while supporting the NHS to adopt solutions that deliver real-world impact for patients and services.